Malabsorption of bile acids and dysfunction of farnesoid-X receptor (FXR)/fibroblast growth factor-19 (FGF19) axis worsen cholestasis and liver fibrosis [18]. This evidence concerns the gene NR1H4 and Hepatic fibrosis.